Form 4 for ADCT ADC Therapeutics SA
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-15 · accession 0001731122-25-000777 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-19 | 2025-05-15 | ADCT | Pfisterer Thomas | See Explanations | J - Other | — | -451.9K | 173.9K | -72% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-05-15 | J | D | 451,856 | — | 173,899 | D | — | — | (F1) In addition to the 173,899 shares still owned by Thomas Pfisterer, he previously held 451,856 shares directly or indirectly via HPWH MH AG ("MH") and HPWH TH AG ("HPWH") but following stepping down from the Board of Directors of MH and HPWH transferred ownership by way of an intragroup sale to Dr. Hans-Peter Wild. |